These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 39329732)

  • 1. Non-Coding RNAs in Myasthenia Gravis: From Immune Regulation to Personalized Medicine.
    Iacomino N; Tarasco MC; Berni A; Ronchi J; Mantegazza R; Cavalcante P; Foti M
    Cells; 2024 Sep; 13(18):. PubMed ID: 39329732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Review on the Role of Non-Coding RNAs in the Pathogenesis of Myasthenia Gravis.
    Ghafouri-Fard S; Azimi T; Hussen BM; Taheri M; Jalili Khoshnoud R
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myasthenia gravis: from autoantibodies to therapy.
    Mantegazza R; Bernasconi P; Cavalcante P
    Curr Opin Neurol; 2018 Oct; 31(5):517-525. PubMed ID: 30156572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etiology of myasthenia gravis: innate immunity signature in pathological thymus.
    Cavalcante P; Cufi P; Mantegazza R; Berrih-Aknin S; Bernasconi P; Le Panse R
    Autoimmun Rev; 2013 Jul; 12(9):863-74. PubMed ID: 23535157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-146a in Myasthenia Gravis Thymus Bridges Innate Immunity With Autoimmunity and Is Linked to Therapeutic Effects of Corticosteroids.
    Bortone F; Scandiffio L; Marcuzzo S; Bonanno S; Frangiamore R; Motta T; Antozzi C; Mantegazza R; Cavalcante P; Bernasconi P
    Front Immunol; 2020; 11():142. PubMed ID: 32210951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel infection- and inflammation-associated molecular signature in peripheral blood of myasthenia gravis patients.
    Barzago C; Lum J; Cavalcante P; Srinivasan KG; Faggiani E; Camera G; Bonanno S; Andreetta F; Antozzi C; Baggi F; Calogero RA; Bernasconi P; Mantegazza R; Mori L; Zolezzi F
    Immunobiology; 2016 Nov; 221(11):1227-36. PubMed ID: 27387891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving understandings for the roles of non-coding RNAs in autoimmunity and autoimmune disease.
    Cheng Z; Hou G; Shen N
    J Autoimmun; 2023 May; 137():102948. PubMed ID: 36357241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting autoimmune mechanisms by precision medicine in Myasthenia Gravis.
    Cavalcante P; Mantegazza R; Antozzi C
    Front Immunol; 2024; 15():1404191. PubMed ID: 38903526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune mechanisms in myasthenia gravis.
    Cavalcante P; Bernasconi P; Mantegazza R
    Curr Opin Neurol; 2012 Oct; 25(5):621-9. PubMed ID: 22941261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA signature associated with treatment response in myasthenia gravis: A further step towards precision medicine.
    Cavalcante P; Mizrachi T; Barzago C; Scandiffio L; Bortone F; Bonanno S; Frangiamore R; Mantegazza R; Bernasconi P; Brenner T; Vaknin-Dembinsky A; Antozzi C
    Pharmacol Res; 2019 Oct; 148():104388. PubMed ID: 31401213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage.
    Tsai CY; Shen CY; Liu CW; Hsieh SC; Liao HT; Li KJ; Lu CS; Lee HT; Lin CS; Wu CH; Kuo YM; Yu CL
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33291347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized Medicine.
    Sabre L; Punga T; Punga AR
    Front Immunol; 2020; 11():213. PubMed ID: 32194544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating microRNAs as potential biomarkers in myasthenia gravis patients.
    Punga AR; Punga T
    Ann N Y Acad Sci; 2018 Jan; 1412(1):33-40. PubMed ID: 29125182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and scientific aspects of acetylcholine receptor myasthenia gravis.
    Keijzers M; Nogales-Gadea G; de Baets M
    Curr Opin Neurol; 2014 Oct; 27(5):552-7. PubMed ID: 25105461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-Coding RNA and Innate Immune Signal Regulation].
    Qiu XM; Li X; Liu R
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 53(1):20-27. PubMed ID: 35048595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Genomic, phenotype and epigenetic insights into the pathology, autoimmunity and weight management of patients with Myasthenia Gravis (Review).
    Golfinopoulou R; Papageorgiou L; Efthimiadou A; Bacopoulou F; Chrousos GP; Eliopoulos E; Vlachakis D
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34225443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards Personalized Medicine in Myasthenia Gravis: Role of Circulating microRNAs miR-30e-5p, miR-150-5p and miR-21-5p.
    Beretta F; Huang YF; Punga AR
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating miRNAs drive personalized medicine based on subgroup classification in myasthenia gravis patients.
    Huang X; Zhang Z; Wang Y; Xu M; Du X; Zhang Y
    Neurol Sci; 2023 Nov; 44(11):3877-3884. PubMed ID: 37402938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of miRNAs in Normal and Myasthenia Gravis Thymus.
    Cron MA; Guillochon É; Kusner L; Le Panse R
    Front Immunol; 2020; 11():1074. PubMed ID: 32587589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiological mechanisms of autoimmunity.
    Sudres M; Verdier J; Truffault F; Le Panse R; Berrih-Aknin S
    Ann N Y Acad Sci; 2018 Feb; 1413(1):59-68. PubMed ID: 29377165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.